• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Immunol . Seasonal Betacoronavirus Antibodies' Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization

tetano

Editor, Senior Moderator
J Clin Immunol


. 2022 Jan 9.
doi: 10.1007/s10875-021-01190-5. Online ahead of print.
Seasonal Betacoronavirus Antibodies' Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization


Stefania Dispinseri[SUP] 1 [/SUP], Ilaria Marzinotto[SUP] 2 [/SUP], Cristina Brigatti[SUP] 2 [/SUP], Maria Franca Pirillo[SUP] 3 [/SUP], Monica Tolazzi[SUP] 1 [/SUP], Elena Bazzigaluppi[SUP] 2 [/SUP], Andrea Canitano[SUP] 3 [/SUP], Martina Borghi[SUP] 4 [/SUP], Alessandra Gallinaro[SUP] 3 [/SUP], Roberta Caccia[SUP] 5 [/SUP], Riccardo Vercesi[SUP] 5 [/SUP], Paul F McKay[SUP] 6 [/SUP], Fabio Ciceri[SUP] 7 8 [/SUP], Lorenzo Piemonti[SUP] 2 7 [/SUP], Donatella Negri[SUP] 4 [/SUP], Paola Cinque[SUP] 5 [/SUP], Andrea Cara[SUP] 3 [/SUP], Gabriella Scarlatti[SUP] 9 [/SUP], Vito Lampasona[SUP] 10 [/SUP]



Affiliations

Abstract

SARS-CoV-2 vaccination is known to induce antibodies that recognize also variants of concerns (VoCs) of the virus. However, epidemiological and laboratory evidences indicate that these antibodies have a reduced neutralization ability against VoCs. We studied binding and neutralizing antibodies against the Spike protein domains and subunits of the Wuhan-Hu-1 virus and its alpha, beta, delta VoCs and of seasonal betacoronaviruses (HKU1 and OC43) in a cohort of 31 health care workers prospectively followed post-vaccination with BNT162b2-Comirnaty. The study of sequential samples collected up to 64 days post-vaccination showed that serological assays measuring IgG against Wuhan-Hu-1 antigens were a poor proxy for VoC neutralization. In addition, in subjects who had asymptomatic or mild COVID-19 prior to vaccination, the loss of nAbs following disease could be rapid and accompanied by post-vaccination antibody levels similar to those of naïve vaccinees. Interestingly, in health care workers naïve for SARS-CoV-2 infection, vaccination induced a rapid and transient reactivation of pre-existing seasonal coronaviruses IgG responses that was associated with a subsequent reduced ability to neutralize alpha and beta VoCs.

Keywords: Antibodies; COVID-19; Neutralizing antibodies; Vaccine.
 
Back
Top Bottom